JP Morgan Put 790 LLY 16.01.2026/ DE000JK7RM11 /
2024-05-31 11:01:48 AM | Chg.-0.02 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.00EUR | -1.96% | - Bid Size: - |
- Ask Size: - |
ELI LILLY | 790.00 - | 2026-01-16 | Put |
GlobeNewswire
05-30
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire
05-30
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire
05-24
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
05-23
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
05-16
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
05-16
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
05-15
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire
05-13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
05-09
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
05-09
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
05-08
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
05-08
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire
05-08
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-03
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire
05-01
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors